£144.12

Springer Cancer Immunology and Immunotherapy: 344 (Current Topics in Microbiology and Immunology, 344)

Price data last checked 91 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 1 year ago.

£144 today · all-time low £139 (Feb 2025) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 640 days • 640 data points (No recent data available)

Historical
Generating forecast...
£179.99 £135.42 £145.14 £154.87 £164.59 £174.32 £184.04 09 June 2024 15 November 2024 24 April 2025 01 October 2025 10 March 2026

Price Distribution

Price distribution over 640 days • 7 price levels

Days at Price
Current Price
312 days 47 days 71 days 61 days 64 days · current 75 days 10 days 0 78 156 234 312 £139 £141 £142 £143 £144 £146 £180 Days at Price

Price Analysis

Most common price: £139 (312 days, 48.8%)

Price range: £139 - £180

Price levels: 7 different prices over 640 days

Description

The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
98% match

Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors

Springer

£156.60 12 Jan 2026
Springer - Immunotherapy of Cancer: An Innovative Treatment
98% match

Springer - Immunotherapy of Cancer: An Innovative Treatment

Springer

£110.34 18 Apr 2026
Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)
98% match

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Springer

£87.93 12 Apr 2026
Cancer Immunotherapy (Advances in Immunology): Volume 90
98% match

Cancer Immunotherapy (Advances in Immunology): Volume 90

Academic Press

£61.72 17 Mar 2026
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
98% match

Cancer Immunology: Bench to Bedside Immunotherapy of Cancers

Springer

£156.60 11 Jan 2026
Cancer Immunology: A Translational Medicine Context
97% match

Cancer Immunology: A Translational Medicine Context

Springer

£116.13 27 Feb 2026
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
97% match

Cancer Immunology: Bench to Bedside Immunotherapy of Cancers

£110.06 13 Jan 2026
Mechanisms of Tumor Escape from the Immune Response (Tumor Immunology and Immunotherapyseries, 1)
97% match

Mechanisms of Tumor Escape from the Immune Response (Tumor Immunology and Immunotherapyseries, 1)

CRC Press

£79.41 08 Mar 2026
Progress in Cancer Immunotherapy: 909 (Advances in Experimental Medicine and Biology, 909)
97% match

Progress in Cancer Immunotherapy: 909 (Advances in Experimental Medicine and Biology, 909)

Springer

£103.81 07 Jan 2026
Immunotherapy of Cancer (Cancer Drug Discovery and Development)
97% match

Immunotherapy of Cancer (Cancer Drug Discovery and Development)

Humana

£67.77 10 Mar 2026
Immunotherapy of Cancer (Cancer Drug Discovery and Development)
97% match

Immunotherapy of Cancer (Cancer Drug Discovery and Development)

Humana

£147.58 12 Jan 2026
Immunodiagnosis and Immunotherapy of Malignant Tumors: Relevance to Surgery
97% match

Immunodiagnosis and Immunotherapy of Malignant Tumors: Relevance to Surgery

Springer

£89.36 08 Mar 2026
Developments in T Cell Based Cancer Immunotherapies (Cancer Drug Discovery and Development)
97% match

Developments in T Cell Based Cancer Immunotherapies (Cancer Drug Discovery and Development)

Humana

£112.39 31 Jan 2026
Cancer Vaccines: From Research to Clinical Practice
97% match

Cancer Vaccines: From Research to Clinical Practice

CRC Press

£175.44 18 Feb 2026
Immunotherapy in Translational Cancer Research (Translational Oncology)
97% match

Immunotherapy in Translational Cancer Research (Translational Oncology)

Wiley

£135.04 24 Jan 2026
Critical Developments in Cancer Immunotherapy
97% match

Critical Developments in Cancer Immunotherapy

£421.00 12 Apr 2026
Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)
97% match

Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)

CRC Press

£188.36 08 Mar 2026
Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)
97% match

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Humana

£73.91 07 Mar 2026
Cancer Immunotherapy: Immune Suppression and Tumor Growth
97% match

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Academic Press

£77.00 24 Feb 2026
Immunotherapy of Cancer (Volume 128) (Advances in Cancer Research, Volume 128)
97% match

Immunotherapy of Cancer (Volume 128) (Advances in Cancer Research, Volume 128)

Academic Press

£111.95 09 Mar 2026
CRC Press - Tumor Immunology and Cancer Therapy: 61 Book
97% match

CRC Press - Tumor Immunology and Cancer Therapy: 61 Book

CRC Press

£76.59 10 Mar 2026
The Tumor Immunoenvironment
97% match

The Tumor Immunoenvironment

Springer

£149.60 10 Feb 2026
Inflammation and Immunity in Cancer
97% match

Inflammation and Immunity in Cancer

Springer

£112.86 08 Mar 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
97% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£113.48 18 Apr 2026